Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

NCT03915470 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Infections
Surgical Site Infection

Interventions

DRUG: XF-73
DRUG: Placebo

Sponsor

Destiny Pharma Plc